View Author
patient psoriasis treatment study therapy guideline evidence dermatol ciclosporin effect dermatology efalizumab methotrexate table response disease infection plaque psoriasis grade author journal result combination factor infliximab european etanercept trial psoriasis vulgaris adalimumab efficacy reaction pasi 75 response level vulgari 12 weeks group plaque phototherapy compilation suppl quality increase arthritis safety jeadv liver side effects improvement dermatologist venereology academy 5–70 venereology guidelines pregnancy measure exposure pasi /bsa arthritis venereology pathirana symptom interaction acitretin malignancy reduction contraindication © 2009 retinoid randomized assessment serum placebo pasi 75 month recommendation 5 mg /kg alefacept erythema fumaric acid esters blood drug reactions
7 Most Recent Publications
|
How good are clinical severity and outcome measures for psoriasis: Quantitative evaluation in a systematic review
(Article)
Spuls, P.I. Lecluse, L.L.A. Poulsen, M.L.N.F. Bos, J.D. Stern, R.S. Nijsten, T.E.C. |
2010-04-01
|
|
European S3-guidelines on the systemic treatment of psoriasis vulgaris
(Article)
Pathirana, D. Ormerod, A.D. Dubertret, L. Eberlein, B. Erdmann, R. Ferguson, J. Girolomoni, G. Gisondi, P. Giunta, A. Griffiths, C.E.M. Hönigsmann, H. Hussain, M. Saiag, P. Jobling, R. Karvonen, S.L. Kemeny, L. Kopp, I. Leonardi, C. MacCarone, M. Menter, A. Mrowietz, U. Naldi, L. Nijsten, T.E.C. Smith, C. Ortonne, J.P. Orzechowski, H.D. Rantanen, T. Reich, K. Reytan, N. Richards, H. Thio, H.B. Kerkhof, P.C.M. van de Rzany, B. Spuls, P.I. Nast, A. Barker, J. Bos, J.D. Burmester, G.R. Chimenti, S. |
2009-10-01
|
|
The misperception that clinical trial data reflect long-term drug safety: Lessons learned from efalizumab's withdrawal
(Article)
Nijsten, T.E.C. Spuls, P.I. Naldi, L. Stern, R.S. |
2009-09-01
|
|
STROBE: A beaconfor observational studies
(Article)
Nijsten, T.E.C. Spuls, P.I. Stern, R.S. |
2008-09-01
|
|
Knowledge, attitudes and use of the guidelines for the treatment of moderate to severe plaque psoriasis among Dutch dermatologists
(Article)
Wakkee, M. Lugtenberg, M. Spuls, P.I. Jong, E.M. de Thio, H.B. Westert, G. Nijsten, T.E.C. |
2008-08-01
|
|
Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis
(Article)
Nijsten, T.E.C. Spuls, P.I. |
2008-07-01
|
|
Evaluation of the reimbursement criteria for biological therapies for psoriasis in the Netherlands
(Article)
Wakkee, M. Thio, H.B. Spuls, P.I. Jong, E.M. de Nijsten, T.E.C. |
2008-05-01
|